✦ LIBER ✦

Risk Factors for Lymphoma in Patients With Inflammatory Bowel Disease: A Case-Control Study

✍ Scribed by Waqqas Afif; William J. Sandborn; William A. Faubion; Meher Rahman; William S. Harmsen; Alan R. Zinsmeister; Edward V. Loftus

Book ID: 119432016
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 290 KB
Volume: 140
Category: Article
ISSN: 0016-5085
DOI: 10.1016/s0016-5085(11)60168-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Incidence and risk factors for gallstone

Incidence and risk factors for gallstones in patients with inflammatory bowel disease: A large case-control study

✍ Fabrizio Parente; Luca Pastore; Stefano Bargiggia; Claudia Cucino; Salvatore Gre 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB 👁 1 views

The risk for gallstones (GD) in inflammatory bowel diseases and the factors responsible for this complication have not been well established. We studied the incidence of GD in a cohort of Crohn's disease (CD) and ulcerative colitis (UC) patients and investigated the related risk factors. A case-cont

Genetic risk factors in patients with in

Genetic risk factors in patients with inflammatory bowel disease and vascular complications: Case-control study

✍ I.E. Koutroubakis; A. Sfiridaki; G. Tsiolakidou; A. Theodoropoulou; A. Livadiota 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB 👁 2 views

## Background: Inherited risk factors have been suggested to play an important role in the pathogenesis of vascular complications of inflammatory bowel disease (ibd). the aim of the present study was to investigate the role of mutations associated with cardiovascular disease in ibd patients with or

Dietary risk factors for inflammatory bo

Dietary risk factors for inflammatory bowel disease A Multicenter Case-Control Study in Japan

✍ Naomasa Sakamoto; Suminori Kono; Kenji Wakai; Yoshihiro Fukuda; Masamichi Satomi 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB

Population-based cases control study of

Population-based cases control study of inflammatory bowel disease risk factors

✍ Richard B Gearry; Ann K Richardson; Christopher M Frampton; Andrew J Dodgshun; M 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 195 KB

Risk of malignant lymphoma in patients w

Risk of malignant lymphoma in patients with inflammatory bowel diseases: A Dutch nationwide study

✍ A.C.W. Vos; N. Bakkal; R.C. Minnee; M.K. Casparie; D.J. de Jong; G. Dijkstra; P. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 319 KB 👁 2 views

Background: Immune suppressant medications such as thiopurines and anti-tumor necrosis factor agents are important for maintaining disease control in most patients with inflammatory bowel diseases (IBDs); however, their use has been associated with the development of malignant lymphoma. The purpose

Risk Factors for Opportunistic Infection

Risk Factors for Opportunistic Infections in Patients With Inflammatory Bowel Disease

✍ Murat Toruner; Edward V. Loftus Jr; W. Scott Harmsen; Alan R. Zinsmeister; Rober 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 149 KB